BeyondSpring (BYSI) Prepaid Assets (2015 - 2026)
BeyondSpring (BYSI) posted Prepaid Assets of $181000.0 for Q1 2026, up 154.93% sequentially from $71000.0 in Q4 2025, and up 101.11% YoY from $90000.0 in Q1 2025.
BeyondSpring (BYSI) Prepaid Assets (2015 - 2026) Analysis & Trends
BeyondSpring has reported Prepaid Assets for 12 years, with the latest figure at $181000.0 in Q1 2026.
- Quarterly Prepaid Assets rose 101.11% year-over-year to $181000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $181000.0 (up 101.11% YoY) and the FY2025 annual result came in at $71000.0, up 4.41% from the prior year.
- Prepaid Assets grew to $181000.0 in Q1 2026 per BYSI's latest filing, from $71000.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $1.6 million in Q2 2022 and troughed at $68000.0 in Q4 2024.
- A 5-year average of $345090.9 and a median of $181000.0 in 2026 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2023 and 2026: Prepaid Assets plunged 86.67% in 2023, then jumped 101.11% in 2026.
- Over 5 years, Prepaid Assets stood at $763000.0 in 2022, then tumbled by 77.98% to $168000.0 in 2023, then tumbled by 59.52% to $68000.0 in 2024, then advanced by 4.41% to $71000.0 in 2025, then jumped by 154.93% to $181000.0 in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $181000.0, $71000.0, and $131000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | BeyondSpring | 29.85 Mn | 29.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 273,000.00 |
| Mar 31, 2026 | 181,000.00 |
| Dec 31, 2025 | 71,000.00 |
| Sep 30, 2025 | 131,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Mar 31, 2025 | 90,000.00 |
| Dec 31, 2024 | 68,000.00 |
| Jun 30, 2024 | 279,000.00 |
| Dec 31, 2023 | 168,000.00 |
| Jun 30, 2023 | 217,000.00 |
| Dec 31, 2022 | 763,000.00 |
| Jun 30, 2022 | 1.63 Mn |
| Dec 31, 2021 | 1.02 Mn |
| Sep 30, 2021 | 1.31 Mn |
| Jun 30, 2021 | 1.28 Mn |
| Mar 31, 2021 | 362,000.00 |
| Dec 31, 2020 | 358,000.00 |
| Sep 30, 2020 | 485,000.00 |
| Jun 30, 2020 | 567,000.00 |
| Mar 31, 2020 | 452,000.00 |